Supply of Medical Products: Reagents for the Unicel Dxi 800 Access Series Analyzer Available to the Customer (2)

RussiaTenders notice for Supply of Medical Products: Reagents for the Unicel Dxi 800 Access Series Analyzer Available to the Customer (2). The reference ID of the tender is 113382712 and it is closing on 22 Jan 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Supply of Medical Products: Reagents for the Unicel Dxi 800 Access Series Analyzer Available to the Customer (2)
  • RUT Ref No: 113382712
  • Deadline: 22 Jan 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 1318724.00
  • Notice Type: Tender
  • Document Ref. No.: 0167200003424011414
  • Purchaser's Detail :
  • Purchaser : PUBLIC PROCUREMENT DEPARTMENT OF TYUMEN REGION
    625003, st. Respubliki, house 24
    Full name:- Bondarenko M.A.
    Contact phone number:- 7-3452-426611
    Fax:- No information
    Email :BondarenkoMA@72to.ru

  • Description :
  • Supply of medical products: reagents for the UniCel DxI 800 Access series analyzer available to the Customer (2)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us